What is a key strategy to minimize pre-analytical errors in the NHCO Order of Draw?

• A. Use only one tube type
• B. Adhere to the standard order of draw, verify patient ID, label correctly, handle and transport specimens properly, and follow QA processes
• C. Draw as quickly as possible without labeling
• D. Ignore QA documentation

Answer: (B)

The main idea is that preventing pre-analytical errors comes from following a complete, careful workflow: use the standard order of draw, verify the patient’s identity, label the specimen correctly, handle and transport it properly, and follow quality assurance processes. When these steps are combined, the risks of misidentification, cross-contamination of tube additives, specimen degradation, and missed issues are greatly reduced.

Why this approach works best: following the standard order of draw prevents additive carryover from one tube to another, which can skew test results. Verifying patient ID ensures the sample actually belongs to the intended patient, avoiding mix-ups. Correct labeling ties the specimen to the right person and the right tests, so results go to the correct chart. Proper handling and transport protect sample integrity and timing, reducing errors like clotting, hemolysis, or temperature damage. QA processes provide ongoing checks, documentation, and corrective actions to catch and fix problems before testing occurs.

Skipping these together creates risk. Using only one tube type ignores the test mix and can disrupt the required additive sequence. Drawing quickly without labeling invites misidentification. Ignoring QA documentation removes the safety nets that catch and prevent errors, undermining the entire pre-analytical process.